• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET Back to Search Results
Catalog Number 000000000000010220
Device Problem Insufficient Information (3190)
Patient Problems Anaphylactic Shock (1703); Chest Pain (1776); Dyspnea (1816)
Event Date 01/06/2014
Event Type  Injury  
Event Description
The customer reported that a patient had an anaphylactic reaction to the last unit of fresh frozen plasma (ffp) during a therapeutic plasma exchange (tpe) procedure.During the procedure, the patient developed shortness of breath and chest pain.A medical code was called.The physician ordered 25 mg benadryl, 125 mg solumedrol, epinephrine im, and fluids via iv in response to the patient reaction.The patient was transferred to sicu briefly.The condition of the patient is now stable and she was discharged home.The customer declined to provide patient identifier.The disposable kit is not available for return because it was discarded by the customer.This report is being filed due to medical intervention in the form of breathing treatment, benadryl, solumedrol, epinephrine im.
 
Manufacturer Narrative
Investigation evaluation and corrective actions are in-process.A follow-up report will be provided.
 
Manufacturer Narrative
The disposable set was unavailable for return and investigation.The run data file was analyzed for this event.A review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.The machine was checked out at the customer site by a terumo bct service technician.No issues were found during checkout.A saline run was completed without incident.Root cause: the kit was unavailable for specific root cause.The d logs did not indicate an abnormal procedure.The machine was evaluated and determined to be functioning as intended.Based on the spectra optia system functioning as intended and the customer's evaluation of the issue, the patient experienced an allergic reaction to the ffp.Per the therapeutic apheresis handbook: a physician's reference, 2nd edition, plasma replacement reactions may occur in approximately 7.8% of procedures, based on the results of a survey of therapeutic procedures.Of these reactions, most were mild and well tolerated.The spectra optia system has many safety features.A donor and/or patient reaction can occur rapidly, however.It is imperative that the operator continuously monitor the spectra optia system and the donor and/or patient.
 
Manufacturer Narrative
This record was identified during a retrospective review of mdrs to identify records in which anevent occurred, but the type of reportable event was not indicated appropriately.This supplement is being filed to modify information to align with thereported event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA EXCHANGE SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer Contact
jessica kim
10811 w. collins ave
lakewood, CO 80215
3032314812
MDR Report Key3602407
MDR Text Key19297644
Report Number1722028-2014-00023
Device Sequence Number1
Product Code GKT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
BK120012
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,health professional
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup
Report Date 01/06/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/01/2015
Device Catalogue Number000000000000010220
Device Lot Number11V3127
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/27/2014
Initial Date FDA Received01/31/2014
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received03/27/2014
06/28/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/30/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age00029 YR
Patient Weight86
-
-